Industry announcement previews a clinical–research collaboration focused on preventive health innovation, offering context on aims and planned steps.
Key Takeaways
- Clinical collaboration will validate proteomic organ-aging biomarkers for preventive medicine applications
- They will apply Vero's OrganAge proteomic platform to measure biological aging across individual organs
- Validated biomarkers aim to enable translational patient care and earlier